EPRX.TO EUPRAXIA PHARMACEUTICALS INC
$11.69▲ +5.51%
Healthcare
Other
Volume 132.6K
Avg Volume (10D) 59.5K
Key Metrics & Fundamentals
Market Cap
$772.40M
P/E Ratio
–
Div Yield
–%
52W Range
7.15 - 12.86
% vs 50 MA
17.04%
% vs 200 MA
11.56%
RSI-14
62.1
MACD Histogram
+0.1600
Beta (1Y vs SPY)
1.44
Free Cash Flow
-$10.47M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$18.11M
COGS
–
Operating Exp
$15.96M
Operating Income
-$15.96M
EBIT
-$15.96M
Pretax Income
-$12.64M
Net Income
-$12.65M
EPS (Diluted)
-0.23
Price & Volume History
Loading chart…
Recent News
Eupraxia Pharma (EPRX): When Painful Swallowing Nearly Disappeared, Investors Took Notice
Insider Monkey · Sep 12, 2026 7:56 AM
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
GlobeNewswire · Sep 8, 2026 12:00 PM
Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Painful Swallowing) in Eosinophilic Esophagitis Patients
GlobeNewswire · Aug 13, 2026 12:00 PM
Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 11, 2026 9:21 PM
Wall Street Analysts See a 145.35% Upside in Eupraxia Pharmaceuticals Inc. (EPRX): Can the Stock Really Move This High?
Zacks · Aug 10, 2026 1:55 PM
Top Premarket Decliners
MT Newswires · Jul 28, 2026 11:29 AM
Eupraxia Pharmaceuticals Announces Executive Leadership Changes
MT Newswires · Jul 13, 2026 8:37 PM
Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth
GlobeNewswire · Jul 13, 2026 8:05 PM
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
GlobeNewswire · Jul 7, 2026 12:00 PM
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
GlobeNewswire · Jun 19, 2026 8:02 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See EPRX.TO's money flow as a full page
Social Sentiment
No Reddit posts found for EPRX.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.